St. Jude Medical (STJ)

Sector:
HEALTH CARE
Industry:
HEALTH CARE
SIC:
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
CEO:
Michael T. Rousseau
Employees:
18,000
ONE ST JUDE MEDICAL DRIVE, ST PAUL, MN 55117
6517562000

• *** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

St. Jude Medical, Inc., together with its subsidiaries, develops, manufactures, and distributes cardiovascular medical devices for cardiac rhythm management, cardiovascular, and atrial fibrillation therapy areas worldwide.

Data derived from most recent annual or quarterly report
Market Cap 23.092 Billion Shares Outstanding285.716 Million Avg 30-day Volume 2.924 Million
P/E Ratio35.1526 Dividend Yield1.5296 EPS1.91
Price to Revenue3.8835 Debt to Equity1.2871 EBITDA1.278 Billion
Price to Book Value5.1561 Operating Margin15.5138 Enterprise Value28.51 Billion
Current Ratio1.933 EPS Growth-0.354 Quick Ratio1.156
1 Yr BETA 0.6705 52-week High/Low 0.0 / Profit Margin11.0477
Operating Cash Flow Growth-12.7796 Altman Z-Score3.049 Free Cash Flow to Firm -2.495 Billion
View SEC Filings from STJ instead.

View recent insider trading info

St. Jude Medical YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding STJ (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding STJ

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 4: filed on 2017-01-06 by ST JUDE MEDICAL INC
  • 4: filed on 2017-01-06 by ST JUDE MEDICAL INC
  • 4: filed on 2017-01-06 by ST JUDE MEDICAL INC
  • 4: filed on 2017-01-06 by ST JUDE MEDICAL INC
  • 4: filed on 2017-01-06 by ST JUDE MEDICAL INC
  • 4: filed on 2017-01-06 by ST JUDE MEDICAL INC
  • 4: filed on 2017-01-06 by ST JUDE MEDICAL INC
  • 4: filed on 2017-01-06 by ST JUDE MEDICAL INC
  • 4: filed on 2017-01-06 by ST JUDE MEDICAL INC
  • 4: filed on 2017-01-06 by ST JUDE MEDICAL INC

    • Events (8k)

  • 8-K: filed on 2017-01-05:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 1.02: Termination of a Material Definitive Agreement
    Item 2.01: Completion of Acquisition or Disposition of Assets
    Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
    Item 3.03: Material Modifications to Rights of Security Holders
    Item 5.01: Changes in Control of Registrant
    Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2016-10-27:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
    Item 5.07: Submission of Matters to a Vote of Security Holders
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2016-10-19:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2016-10-18:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2016-07-20:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2016-07-12:
    Item 8.01: Other Events
  • 8-K: filed on 2016-06-07:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2016-04-28:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2016-04-20:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2016-01-13:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits

    • Proposed Sales (Form 144)

    Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    STARKS DANIEL J

    • Director
    		 No longer subject to file 2017-01-04 0

    ROCCA MICHAEL A

    • Director
    		 No longer subject to file 2017-01-04 0

    YARNO WENDY L

    • Director
    		 No longer subject to file 2017-01-04 0

    BROWN JOHN W

    • Director
    		 No longer subject to file 2017-01-04 0

    ESSIG STUART

    • Director
    		 No longer subject to file 2017-01-04 0

    HEINMILLER JOHN C EXECUTIVE VICE PRESIDENT

    • Officer
    		 No longer subject to file 2017-01-04 0

    DEVENUTI RICHARD R

    • Director
    		 No longer subject to file 2017-01-04 0

    ROUSSEAU MICHAEL T DIRECTOR, PRESIDENT AND CEO

    • Officer
    • Director
    		 No longer subject to file 2017-01-04 0

    WIDENSOHLER STEFAN K

    • Director
    		 No longer subject to file 2017-01-04 0

    HILL BARBARA B

    • Director
    		 No longer subject to file 2017-01-04 0

    DVORAK DAVID C

    • Director
    		 No longer subject to file 2017-01-04 0

    ZURBAY DONALD VP FINANCE AND CFO

    • Officer
    		 No longer subject to file 2017-01-04 0

    BAE I PAUL VP GLOBAL HR AND CCO

    • Officer
    		 No longer subject to file 2017-01-04 0

    FAIN ERIC S GROUP PRESIDENT

    • Officer
    		 No longer subject to file 2017-01-04 0

    GESTIN DENIS M PRESIDENT, INTERNATIONAL

    • Officer
    		 No longer subject to file 2017-01-04 0

    ZELLERS JASON VP, GENERAL COUNSEL & CORP SEC

    • Officer
    		 No longer subject to file 2017-01-04 0

    FECHO JEFF VP, GLOBAL QUALITY

    • Officer
    		 No longer subject to file 2017-01-04 0

    ELLINGSON RACHEL VP, GLOBAL COMMUNICATIONS

    • Officer
    		 No longer subject to file 2017-01-04 0

    MURPHY MARK W. VP, IT AND CIO

    • Officer
    		 No longer subject to file 2017-01-04 0

    CARLSON MARK CHIEF MEDICAL OFF-VP,CLINICAL

    • Officer
    		 No longer subject to file 2017-01-04 0

    ANDRADE LISA VP AND CHIEF MARKETING OFFICER

    • Officer
    		 No longer subject to file 2017-01-04 0

    DALLAGER JEFF VP AND CORPORATE CONTROLLER

    • Officer
    		 No longer subject to file 2017-01-04 0

    THOME SCOTT VP, GLOBAL OPS & SUPPLY CHAIN

    • Officer
    		 No longer subject to file 2017-01-04 0

    EBELING PHILIP VP, CHIEF TECHNOLOGY OFFICER

    • Officer
    		 No longer subject to file 2017-01-04 0

    BECKER JOEL PRESIDENT, AMERICAS

    • Officer
    		 5,223 2015-12-17 0

    CRAIG ANGELA D VP - GLOBAL HUMAN RESOURCES

    • Officer
    		 8,859 2014-12-17 0

    CALLAGHAN FRANK J PRESIDENT, CATD

    • Officer
    		 4,514 2013-12-14 0

    CHESTER KATHY VP, GLOBAL REGULATORY

    • Officer
    		 4,830 2013-10-29 0

    NORTHENSCOLD THOMAS R VP, IT AND CIO

    • Officer
    		 4,177 2013-02-05 0

    GARRETT THOMAS H III

    • Director
    		 0 2012-05-03 0

    SONG JANE PRESIDENT, AF DIVISION

    • Officer
    		 29,374 2011-12-14 0

    KHOSRAVI BEHZAD VP, GLOBAL QUALITY

    • Officer
    		 35,989 2011-12-14 0

    HOARE ROHAN PRESIDENT - NMD

    • Officer
    		 3,188 2011-12-14 0

    KROP PAMELA SUE VP, GENERAL COUNSEL & SEC.

    • Officer
    		 4,423 2011-05-03 0

    CHAVEZ CHRISTOPHER G PRESIDENT, ANS DIVISION

    • Officer
    		 0 2010-12-14 0

    MCCULLOUGH JOSEPH H GROUP PRESIDENT

    • Officer
    		 0 2008-12-15 0

    FAZIO GEORGE PRESIDENT, US DIVISION

    • Officer
    		 16,732 2008-07-23 0

    COYLE MICHAEL J PRESIDENT, CRMD

    • Officer
    		 130,709 2007-06-20 0

    THOMPSON DAVID

    • Director
    		 71,200 2006-05-10 0

    OMALLLEY KEVIN T VP & GENERAL COUNSEL

    • Officer
    		 311,644 2006-02-01 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
    No current insider transactions

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    Elevate your investments